FDA Seeks To Amend Drugs' Pregnancy Labeling
The U.S. Food and Drug Administration has proposed a change of its prescription-drug-labeling regulations that would require labels to include a summary of the risks of use during pregnancy and breast-feeding....To view the full article, register now.
Already a subscriber? Click here to view full article